CCO at AlloVir

AlloVir, a late-clinical stage allogeneic T cell immunotherapy company, today announced the appointment of Cintia Piccina, PharmD, MBA, as the company’s Chief Commercial Officer, effective June 12, 2023. Ms. Piccina will drive the global commercialization strategy for AlloVir, with a focus on its lead product, posoleucel, and be responsible for building a commercial team in anticipation of a 2025 launch.

CFO at Impel Pharmaceuticals

Impel Pharmaceuticals, a commercial-stage biopharmaceutical company with a mission to develop transformative therapies for people suffering from diseases with high unmet medical needs, today announced the appointment of Michael W. Kalb, CPA, as Chief Financial Officer, effective May 10, 2023.

CFO at Cognition Therapeutics

Cognition Therapeutics, Inc., today announced the appointment of John Doyle to the role of Chief Financial Officer. Mr. Doyle has substantial experience leading and managing financial operations at development- and commercial-stage public life sciences companies through financings, mergers, acquisitions and licensing agreements.

Board Member at Keros Therapeutics

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological, pulmonary and cardiovascular disorders with high unmet medical need, today announced that it appointed Alpna Seth, Ph.D., to its Board of Directors, effective May 1, 2023.

Board Member at Impel Pharmaceuticals

Impel Pharmaceuticals (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, today announced the appointment of Darren Cline to the Board of Directors. 

Non-Executive Chairman at Venatorx Pharmaceuticals

“We are pleased to welcome Tom Heyman to our Board of Directors, “ said Christopher J. Burns, President and Chief Executive Officer. “As a highly respected and seasoned executive and board member, Tom brings a diverse breadth of industry experience across multiple disciplines that will benefit Venatorx as we continue to progress our pipeline of novel anti-infective therapies.

CMO at Shoreline Biosciences

Dr. Avanzi is an experienced physician-scientist and hematologist/oncologist with over fifteen years of clinical experience, including over ten years of experience advancing cellular therapies through early and late-stage of development.  In his new role, Dr. Avanzi will be responsible for leading and expanding Shoreline’s clinical portfolio and will serve as a key member of its Executive team.

CBO & CHRO at Elektrofi

Elektrofi strengthens leadership team with appointments of Greg DeFilippis as Chief Business Officer and Paulette Gangemi as Chief Human Resources Officer

CFO at Apogee Therapeutics

“Jane is a highly accomplished leader and multiple time CFO with significant expertise in corporate strategy and finance in the healthcare sector, and we are excited to welcome her to our leadership team,” said Michael Henderson, M.D., CEO of Apogee Therapeutics. “Her unique combination of experience as a seasoned biopharmaceutical executive and investment banker will help propel Apogee forward in its ...

CEO at Curve Health

Curve Health names Healthcare Veteran Matthew A. Michela as CEO to expand reach of senior care platform.